Search Results 1491-1500 of 38505 for oral
The study will evaluate oral daily administration of eFT508. Treatment and study subject evaluation will be performed in 21-day cycles. Participation ...
This phase II trial studies how well giving ruxolitinib phosphate (oral JAK inhibitor INCB18424) works in treating patients with relapsed or refractory diffuse ...
Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection · More about research at Mayo Clinic.
Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. · More about research at Mayo Clinic.
Levamisole is used with another cancer medicine (fluorouracil) to help make it work better against cancer of the colon. Levamisole is available only with your ...
The purpose of this study is to analyze breast tissue changes after a short course of Tamoxifen (Tam). Participation eligibility. Participant eligibility ...
For oral dosage form (tablets):. For hypercortisolemia: Adults—At first, 150 milligrams (mg) 2 times a day. Your doctor may adjust your dose as needed and ...
Comprehensive, consultative, and emergency pediatric oral health services; Preventive and therapeutic pediatric dental services for individuals with complex ...
Registry of Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Thromboembolic Prevention in Patients with Congenital Heart Disease.
The purpose of this study is to evaluate whether prolonged oral levosimendan can preserve respiratory function more effectively than placebo, resulting in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!